CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Large Increase in Short Interest

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 190,400 shares, a growth of 2,438.7% from the October 31st total of 7,500 shares. Based on an average daily volume of 241,500 shares, the short-interest ratio is currently 0.8 days.

CNBX Pharmaceuticals Stock Performance

Shares of CNBX Pharmaceuticals stock remained flat at $0.01 on Wednesday. 51 shares of the stock traded hands, compared to its average volume of 185,225. The firm has a 50 day moving average of $0.01 and a 200-day moving average of $0.01. CNBX Pharmaceuticals has a 1 year low of $0.01 and a 1 year high of $0.02.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.